Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Does humira biosimilars contain citrate as an ingredient?

See the DrugPatentWatch profile for humira

Do Humira Biosimilars Contain Citrate?


No, most Humira biosimilars do not contain citrate as an ingredient. Humira (adalimumab) uses citrate in its formulation as a buffering agent to stabilize the drug at a low pH (around 5.2), which reduces injection pain.[1] Biosimilars, however, often switch to citrate-free buffers like phosphate, succinate, or histidine to improve tolerability and patient comfort—key selling points for competing against Humira's high price.

How Does This Compare to Original Humira?


Humira's citrate buffer contributes to stinging during injection, a common patient complaint. Biosimilars like Amjevita (Amgen), Cyltezo (Boehringer Ingelheim), Hadlima (Organon/Samsung Bioepis), and Yusimry (Coherus) eliminate citrate entirely, using alternatives such as:
- Amjevita: Succinate buffer.
- Cyltezo: No citrate; histidine-based.
- Hadlima: Phosphate buffer in some versions.
This change allows "next-gen" biosimilars to cite lower injection-site pain in studies.[2][3]

Which Biosimilars Still Include Citrate?


A few early or specific versions retain citrate to closely mimic Humira's profile:
- Hulio (from three manufacturers: Biocon/Mylan, Richter Gedeon, and Celltrion): Contains citrate in its formulation.[4]
- Some interchangeable versions like Cyltezo's original may have trace amounts, but most updated ones are citrate-free.
Check exact labeling via FDA approvals, as formulations evolve (e.g., Hadlima added a citrate-free high-concentration option in 2023).[5]

Why Do Biosimilars Drop Citrate?


Citrate enables Humira's stability but increases pain by activating nociceptors. Biosimilar makers redesign buffers to match efficacy while addressing this drawback, often in FDA-approved switches or high-concentration pens. This differentiates them commercially without patent issues, as formulation tweaks aren't protected.[1][6]

What Do Patients Report on Injection Pain?


Real-world data shows citrate-free biosimilars reduce pain scores by 20-50% versus Humira in surveys. For example, Amjevita users report less stinging, aiding adherence in rheumatoid arthritis or psoriasis treatment.[7]

[1]: FDA Label for Humira
[2]: Amjevita Prescribing Information
[3]: Drugs.com - Humira Biosimilars Comparison
[4]: FDA Label for Hulio
[5]: FDA Approvals Database
[6]: DrugPatentWatch.com - Adalimumab Formulation Patents
[7]: Patient Forums and Studies via PubMed



Other Questions About Humira :

ftc patent thicket humira 2023 biosimilar competition humira pret humira interchangeable biosimilars humira pen cost tremfya vs humira Is humira covered by insurance? Abbvie humira patent?

AI-Drug Label Prescribing Information Alignment Report

No report available.

Drug Brand Mention Assessment

Branding Score
57
Visibility
60
Mentioned
Ranking
#1
Sentiment
68
Recommendation Status
mentioned only
Brand Perception
Best Known For

uses citrate in its formulation as a buffering agent


Core Claims
  • Humira (adalimumab) uses citrate in its formulation as a buffering agent
  • Humira's citrate buffer stabilizes the drug at low pH (around 5.2)
  • Humira's citrate buffer contributes to stinging during injection
Differentiators
  • Humira uses citrate as a buffering agent
  • Citrate-free biosimilars eliminate citrate entirely

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Amgen 35%
63 #2 No
Boehringer Ingelheim 35%
63 #3 No
Organon 32%
63 #4 No
Coherus 32%
63 #5 No
Biocon 20%
50 #6 No
Mylan 20%
50 #6 No
Richter Gedeon 20%
50 #6 No
Celltrion 20%
50 #6 No